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Abstract
Autism Spectrum Disorder (ASD) is known to be a heritable neurodevelopmental 
disorder affecting more than 1% of the population but in the majority of ASD cases, the 
genetic cause has not been identified. Parent-of-origin effects have been highlighted as 
an important mechanism in the pathology of neurodevelopmental disorders such as 
Prader-Willi and Angelman Syndrome, with individuals with these syndromes often 
exhibiting ASD symptoms. Consequently, systematic investigation of these effects in 
ASD is clearly an important line of investigation in elucidating the underlying genetic 
mechanisms. Using EMIM, a multinomial modelling approach, we simultaneously 
investigated imprinting, maternal genetic effects and associations in the Autism 
Genome Project (AGP) and Simons Simplex Consortium (SSC) genome-wide 
association datasets. To avoid using the overly stringent genome-wide association study 
(GWAS) significance level, we used a Bayesian threshold that takes into account the 
sample size, allele frequency and any available prior knowledge. Between the two 
datasets, we identified a total of 18 imprinting effects and 68 maternal genetic effects 
that met this Bayesian threshold criteria, but none met the threshold in both datasets. 
We identified imprinting and maternal genetic effects for regions that have previously 
shown evidence for parent-of-origin effects in ASD. Together with these findings, we 
have identified maternal genetic effects not previously identified in ASD at a locus in 
SHANK3 on chromosome 22 and a locus in WBSCR17 on chromosome 7 (associated 
with Williams Syndrome). Both genes have previously been associated with ASD. 
Key words: Autism Spectrum Disorder (ASD), parent-of-origin effects, Bayesian
threshold. 
11 Introduction
Autism Spectrum Disorder (ASD) is a complex and heterogeneous 
neurodevelopmental disorder characterised by patterns of repetitive behaviours and 
deficits in language and social behaviour. ASD is known to be heritable, with earlier 
heritability estimates ranging from 0.85 - 0.92 [1] to a more current heritability estimate 
of 0.524 [2], with most of this believed to be due to common rather than rare variation 
[2]. Gaugler et al. [2] also estimated that 41% of the risk for ASD is due to 
environmental factors which include prenatal, perinatal and postnatal environmental 
factors. Several GWAS studies have been performed on common variants in ASD using 
family studies, but the most significant results from these studies show modest effect 
size [35] and therefore, have low power to replicate [4]. Despite growing evidence 
from investigations of rare and de novo structural and sequence variation in ASD [6], 
the aetiology of the majority of ASD cases remains unexplained, suggesting that there 
are complex genetic mechanisms underlying the disorder. There is also evidence to 
suggest that there is a complex relationship between these underlying genetic factors 
and environmental factors [7]. 
Broadly speaking, parent-of-origin effects consist of genetic effects on the 
phenotype of an offspring that are dependent on the parental origin of the associated 
genetic variant(s). Parent-of-origin effects can occur through numerous mechanisms 
such as genomic imprinting and certain trans-generational effects (for example, 
maternal genetic effects) [8]. Genomic imprinting occurs when the allele from a 
particular parent is silenced and the gene is expressed only by the remaining allele that 
has been inherited from the other parent. Evidence for imprinting has been shown in 
Prader-Willi syndrome and Angleman syndrome [9,10], both syndromes having autistic 
2features and diagnoses [11]. There has been strong suggestive evidence for imprinting 
in ASD in the 7q and 15q regions which warrant further investigation [12]. 
When statistically investigating GWAS data for imprinted genes, we examine the 
transmission of alleles from the parent to the offspring. If there is an over-transmission 
of the variant allele by a particular parent, then this might suggest that there is a 
difference in the expression of the alleles through epigenetic mechanisms (heritable 
changes that do not cause changes in the DNA sequence). For example, if the variant 
allele is over-transmitted from mothers only (i.e. maternal over-transmission), this 
might suggest evidence for nonexpression of the paternally derived allele. 
In addition to imprinting, maternal genetic effects can also occur when the maternal 
genotype exerts an influence on the offsprings phenotype regardless of what genetic 
material has been passed from the mother to the offspring. One way in which this can 
occur is when the mothers genotype affects the development of the foetus through the 
intrauterine environment. There has been evidence of maternal genetic effects in ASD, 
for example, at the GSTP*A gene [13] and the HLA-DR4 gene [14]. There has also 
been some evidence of possible prenatal environmental factors influencing the risk of 
ASD. For example, ASD is more likely in half siblings with a shared mother 
(recurrence rate estimates: 5.2% and 7.3%) compared to half siblings with a shared 
father (estimates: 0% and 3.2%, although sample sizes were small for paternal half 
siblings) [15]. However, more recent estimates based on a larger cohort from Sweden 
have not shown as large a difference [16] (recurrence rates: 3.3% for half siblings with 
shared mother; 2.9% for half siblings with shared father). 
The study of parent-of-origin effects has the potential to identify genetic and 
environmental factors that may be contributing to a complex disorder such as ASD [17]. 
3Therefore, in order to help elucidate the genetic and epigenetic aetiology of ASD, we 
investigated two types of parent-of-origin effects, imprinting and maternal genetic 
effects, in ASD GWAS. Previous studies have investigated parent-of-origin effects in 
ASD [3,4,18,19]. Anney et al. [3,4] investigated imprinting in a secondary analysis in 
the Autism Genome Project (AGP) GWAS datasets using an in-house method reported 
to be similar to the method of Cordell et al. [20], but findings were not considered to be 
statistically significant after correcting for multiple testing. Chaste et al. [5] also 
considered whether the transmission came from the mother or the father in their GWAS 
analysis of the Simons Simplex Collection (SSC) data although no parental-specific 
results are reported. Tsang et al. [18] and Yuan and Dougherty [19] used GWAS data to 
investigate maternal genetic effects in ASD using a case-control type analysis. There 
were no genome-wide significant findings or replicated findings in either of these 
studies [18,19]. 
Our analysis approach differs in that we investigated both imprinting and maternal 
genetic effects simultaneously as maternal genetic effects are known to mimic 
imprinting and vice versa [21,22]. We also included offspring genetic effects 
(associations) in our model to enable us to identify an imprinting effect associated with 
ASD. These parent-of-origin analyses were investigated using Estimation of Maternal, 
Imprinting and interaction effects using Multinomial modelling (EMIM) [23,24], which 
in comparison to other tests has been shown to be the most suitable in terms of power 
and type I errors for this type of data [22]. We also adapted a Bayesian method [25] to 
determine an appropriate noteworthy threshold at each locus (taking into account 
sample size, MAF and prior knowledge) instead of using the genome-wide significance 
levels, which are known to be stringent [26]. 
42 Methods and Materials
2.1 Data
The AGP GWAS family trio dataset is described elsewhere, [3] and [4], and here we 
are using the Stage 2 dataset consisting of 2 931 families. This dataset contains 
approximately one million SNPs genotyped on either the Illumina Infinium 1M-single 
or the Illumina 1M-duo microarray, see Acknowledgments for information on how to 
obtain the data. 
The SSC GWAS consists of data on 2 591 simplex families that were genotyped for 
a million or more SNPs on one of three array versions - Illumina 1Mv1 (333 families), 
Illumina 1Mv3 Duo (1 189 families), or Illumina HumanOmni2.5M (1 069 families) 
Therefore, since imputation is computationally intensive for trio datasets and we needed 
the parental genotype data, we combined the three datasets and investigated SNPs 
common to all three arrays, as was carried out in [5]. See  [5,27,28] for further details 
on the SSC data. 
The AGP GWAS data includes families grouped into two nested diagnostic 
categories, Strict ASD (autism diagnoses met on both ADI and ADOS instruments) and 
Spectrum ASD (autism-spectrum diagnoses met on either the ADI or ADOS 
instruments), as used in [3]. Although not considered in the analyses of the SSC data 
[5], we applied the same ASD phenotype criteria as was used in the AGP [3] to define 
Strict and Spectrum ASD phenotypes within the SSC data. We focus our main analyses 
on the Spectrum phenotype which provides the larger sample sizes for the analyses 
(secondary analyses on the Strict phenotype are provided in the Supplementary 
Information (SI)). 
52.2 Statistical Model
Following an extensive review of the parent-of-origin methodology, described 
elsewhere [22], we used the EMIM [23,24] approach for our analyses. EMIM is a 
multinomial model that directly maximises the multinomial likelihood to detect parent-
of-origin effects and can incorporate missing data (SI for further details). We 
simultaneously investigated offspring genetic effects (associations), maternal genetic 
effects and imprinting effects using EMIM. We did not include mother/offspring 
interactions in our model as the inclusion of mother/offspring interaction parameters 
reduces the power of the model substantially, as is to be expected [22]. Instead 
mother/offspring interaction effects were investigated subsequent to a SNP being 
identified as having an offspring effect and a maternal genetic effect. A multiplicative 
model was assumed for offspring and maternal genotype parameters. The benefit of this 
is two-fold; firstly for ease of investigating the effects in an already complex model and 
secondly, to reduce the number of parameters in the model to help increase power, see 
SI for more details. EMIM has also been extended to use haplotype estimates to help 
increase power for detecting imprinting but this method was not used in this paper [29]. 
2.3 Quality Control Procedures
The Quality Control (QC) follows a standard approach to trio GWAS QC, with 
individuals and SNPs removed when missingness > 0.05, Minor Allele Frequency 
(MAF) < 0.05 and Hardy-Weinberg Equilibrium (HWE) p-value < 0.00001. We limited 
our analyses to complete independent trios (both parents and offspring) to prevent the 
reduction in power that estimating missing data in our model would cause. Full details 
of the QC procedures are given in the SI. After QC, the AGP with a Spectrum 
phenotype contains 2 594 trios and 728 228 SNPs, and the SSC with a Spectrum 
6phenotype contains 2 433 trios and 483 080 SNPs. 
2.4 Bayesian Noteworthy Threshold
Power to detect parent-of-origin effects can be limited [22] and the current genome-
wide significance threshold guidelines are known to be very stringent [25,26,30]. These 
genome-wide significance levels are suggested for all sample sizes (and MAFs) and 
hence do not take into account the power at individual SNPs [25,31]. In order to take 
these factors into account, we adopted a Bayesian method proposed by Wakefield [25] 
to determine an appropriate threshold for identifying noteworthy findings. 
This threshold for Z
2
-score is given by the following: 
Z2 > zB
2 = 2Vn+W
W
 1
2
log Vn+W
Vn
 + log PO
R
,
where Vn is the standard error of the parameter (which is dependent on the sample size, 
n, and MAF), W is the prior variance for the log of the relative risk ∆ (i.e. ∆ ∼ N(0,W)), 
PO is the Prior Odds  (i.e. π0/(1 - π0) where π0 is the prior probability that H0 is true), 
and R is the ratio of costs of type II to type I errors. See SI and [25,31] for more 
information. 
We note that when we are investigating imprinting, it is necessary to have an 
offspring genotype effect present in addition to an imprinting effect. This is required to 
ensure that we do not identify non-disease related imprinted regions that would be 
observed in the general population. For maternal genetic effects, an association is not 
required and we investigate loci where the mothers genotype exerts an influence on the 
offsprings phenotype, regardless of association being present or not. Therefore, we 
calculated separate Z
2
-score thresholds for the Wald Z-score for the association 
parameter (R1) and for the maternal genetic effect parameter (S1). We detect a 
7noteworthy imprinting result when both the association parameter and the imprinting 
parameter meet the threshold (see Figure S2 in SI), whereas we detect a noteworthy 
maternal genetic effect when the maternal genetic effect parameter meets the threshold 
(see Figure S3 in SI). 
We chose the prior variance for the log of the relative risk to be W = [log(2)/1.645]2 
= 0.422 (interpret this as a 5% chance that the relative risk will be larger than 2) to
reflect the low effect sizes in GWAS [32]. Due to the evidence that several hundred to 
thousands of loci are likely to contribute to the complex genetic heterogeneity of ASD 
[33,34], we choose π0 = 1 - 500/1 000 000 = 0.9995, which leads to a prior odds of H0
being true of PO = 1 999. Since the power is limited to detect parent-of-origin effects in 
ASD, and this in turn increases type II errors, we chose the ratio of cost of type II errors 
to type I errors, R, equal to 10, as false negatives cannot be followed up. For more 
details on the choice of these parameters and the sensitivity of the Bayesian threshold to 
these choices see SI. 
3 Results
3.1 Autism Genome Project (AGP)
There were nine noteworthy independent loci showing imprinting effects and there 
were forty independent loci showing maternal genetic effects, see Figure S5 and Tables 
S4 and S5 in the SI for all variants that were above the threshold for offspring genetic 
effect (R1) and imprinting (IM) or were above the threshold for maternal genetic effects 
(S1). Table 1 gives a summary of the results discussed below. Note: IM > 1 indicates a 
maternal over-transmission of the allele and IM < 1 indicates a paternal over-
transmission of the allele, whereas IM = 1 indicates no imprinting effect. 
83.1.1 Autism Genome Project Imprinting Results
The top imprinting result was a maternal over-transmission on chromosome 4, between 
LOC391642 and LOC645641 (rs675680, hg18 chr11:g.28082183A>G, allele = G, IM = 
2.36, Wald p-value = 3.02x10−6), which has not been previously associated with ASD. 
We also found a noteworthy paternal over-transmission in SNPs in the STPG2 gene 
(C4orf37 gene) on chromosome 4 (top SNP, rs10025482, hg18 chr4:g.99272299C>T, 
allele = T, IM = 0.59, Wald p-value = 6.21x10
−6, see Figure S7 in the SI) and this region 
was previously implicated in ASD in [18], where a mother/offspring interaction effect 
was identified in the vicinity of the STPG2 gene (rs28539905  not genotyped, R
2
 = 
0.005). We found no evidence of an interaction effect at rs10025482 (LRT p-value = 
0.33) or in this region. 
3.1.2 Autism Genome Project Maternal Genetic Results
The top result for a maternal genetic effect was on chromosome 5 between the genes 
LOC391845 and LOC574080 (rs4516878, hg18 chr5:g.164271894T>C, allele = C, S1 = 
1.40, Wald p-value = 1.16x10−5). This region has not been previously linked with ASD, 
to our knowledge. In our top results, we also identified two maternal genetic effects that 
were previously implicated as maternal genetic effects or mother/offspring interactions 
in the Early Markers for Autism dataset [18]. The first hit is located on the MAML2
gene on chromosome 11, which was identified as a maternal genetic effect in our 
analyses and in the same region in Tsang et al.s [18] but in opposite directions 
(rs545208, hg18 chr11:g.95619756C>T, allele = T, S1 = 0.74, Wald p-value = 3x10
−5, 
see Figure S8 in the SI). We also identified a maternal genetic effect (rs9870610, hg18 
chr3:g.95619758C>T, allele = T, S1 = 1.33, Wald p-value = 7.24x10
−5, see Figure S9 in 
9the SI) on ROBO2 on chromosome 3. An interaction effect was previously identified in 
the gene ROBO2 in Tsang et al. [18], but we found no evidence of an interaction (LRT 
p-value = 0.34) at rs545208. 
3.2 Simons Simplex Collection (SSC)
There were nine noteworthy imprinting results and there were twenty-eight 
independent noteworthy loci with a maternal genetic effect in the SSC data, see Figure 
S16 and Tables S8 and S9 in the SI and Table 1. 
3.2.1 Simons Simplex Collection Imprinting Results
The top imprinting result was a paternal over-transmission on chromosome 13 in the 
TBC1D4 gene (rs9573533, hg18 chr13:g.74853485G>A, allele = A, IM = 0.59, Wald p-
value = 8.17x10−6). To our knowledge, this area has not been previously linked with 
ASD. We identified a maternal over-transmission in the LRRC16A gene (near the HLA
region) (rs16890706, hg18 chr6:g.25628073G>A, allele = A, IM = 1.86, Wald p-value = 
1.09x10−5), which was previously implicated in language deficits [35]. 
3.2.2 Simons Simplex Collection Maternal Genetic Results
The strongest association for a maternal genetic effect was on chromosome 7 in the 
CHRM2 gene (rs6967953, hg18 chr7:g.136353916G>A, allele = A, S1 = 1.38, Wald p-
value = 6.01x10
-6
). This area has been previously linked with IQ and one of the 
strongest linkage signals reported for ASD occurred at 7q within 1.6kb of the CHRM2
gene [36]. One of our top hits for maternal genetic effects was identified on 
chromosome 22 in the SHANK3 gene (rs5770820, hg18 chr22:g.49497339G>A, allele 
=A, S1 = 1.25, Wald p-value = 5.54x10
−5
, see Figure 1). Disruptions in the SHANK3
gene have been associated with autistic traits and in particular, these disruptions are 
responsible for the development of Phelan-McDermid syndrome and other non-
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syndromic ASDs [37]. Figure 1 shows that there are no SNPs in high LD with 
rs5770820 (the SNP in highest LD was rs739365, R
2
 = 0.65) due to the limited number 
of SNPs common to all three arrays in the SSC dataset. 
We also detected a noteworthy maternal genetic effect on chromosome 7q11.23 in 
the WBSCR17 gene (rs4719103, hg18 chr7:g.70395849G>A, allele = A, S1 = 1.41, Wald 
p-value = 5.48x10
−5
, see Figure S18 in SI), this region is deleted in Williams syndrome 
[38] and it is known that individuals with Williams syndrome exhibit autistic 
behaviours [39,40]. This region was strongly associated with ASD in a Copy Number 
Variant (CNV) study carried out on the SSC dataset [28], and we acknowledge that 
there is a large overlap between the samples analysed here and those in the CNV study. 
Another noteworthy result was found on chromosome 22q, which is a protective 
maternal genetic effect in the GNB1L gene (also known as C22orf29 gene) 
(rs11075447, hg18 chr16:g.60560457A>G, allele = G, S1 = 0.76, Wald p-value = 
9.52x10
−5
), this gene has been linked to ASD and schizophrenia [41]. 
INSERT FIGURE 1 ABOUT HERE  
INSERT TABLE 1 ABOUT HERE 
4 Discussion
To our knowledge, this is the first genome-wide study to test for both imprinting and 
maternal genetic effects simultaneously in ASD. This is also the first study to 
implement the Bayesian thresholds that take into consideration the sample size and 
MAF at each SNP, and prior knowledge of effect size and prior odds of finding 
associations. We analysed the AGP and SSC ASD datasets for parent-of-origin effects, 
specifically imprinting and maternal genetic effects. Previous studies of parent-of-origin 
effects in ASD only investigated either imprinting effects or maternal genetic effects 
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[3,4,18,19] despite the fact that these effects are known to mimic each other. We 
identified a total of 18 imprinting effects and 68 maternal genetic effects that met this 
Bayesian threshold criteria in either the AGP or SSC datasets with a Spectrum 
phenotype. None of these results were identified in both datasets. The SI contains 
further analyses of parent-of-origin effects in the AGP and SSC datasets for a Strict 
ASD phenotype, where we identified 10 imprinting effects and 72 maternal genetic 
effects that met the Bayesian threshold criteria in either datasets. A proportion (10-20%) 
of the results identified using a Strict ASD phenotype overlap with the results identified 
using the Spectrum ASD phenotype (see SI for further details). 
This model is complex as it includes three parameters, offspring genetic effects, 
imprinting effects and maternal genetic effects, which can reduce power and can lead to 
the results being harder to interpret. In order to help identify noteworthy findings, we 
adopted a Bayesian threshold proposed by Wakefield [25] to investigate parent-of-
origin effects as it facilitates ease of interpretation of an imprinting effect and a 
maternal genetic effect. Additionally, the Bayesian threshold avoids the use of the 
overly stringent genome-wide significance threshold [25,26]. The Bayesian threshold 
takes into account the sample size and MAF as well as other prior knowledge regarding 
ASD (for example, effect size) to allow for a more appropriate threshold for the model 
at each locus. The Bayesian threshold does not depend on the number of tests performed 
but instead depends on the prior odds. If a Bonferroni correction was employed, or the 
stringent GWAS threshold, then the noteworthy hits we identified would have been 
missed, but as we have shown, some of these hits show promise by being previously 
identified in ASD studies (see Table 1). In addition, we have accounted for the rate of 
true positives and true negatives in the prior odds in the Bayesian threshold, which is a 
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superior method in comparison to using the Bonferroni correction or the GWAS 
thresholds, which do not account for these. 
Replicating results identified in a discovery analysis in an independent sample is the 
gold standard in GWAS analysis as it provides convincing statistical evidence for 
association, and has the potential to rule out associations due to biases [42]. Replication 
generally involves identifying the significant results in the discovery analysis and 
examining these in a replication dataset that is as close to the ascertainment and design 
of the original GWAS as possible [43]. It is important for a replication dataset to be 
independent of the primary dataset, have large enough sample sizes and have the same 
ascertainment and study design as the discovery GWAS [42,43]. 
The AGP and SSC datasets did not have the same ascertainment criteria and these 
differences have led to key differences in the AGP and SSC datasets. The AGP contains 
both simplex and multiplex families (approximately 38% of families are simplex [44]) 
with the aim being to investigate common variation whereas the SSC data contains only 
simplex families, a design which inherently enriches for rare and de novo mutations 
[28,33]. In addition, the SSC dataset excluded families with parents who met criteria for 
a spectrum diagnosis based on two instruments, thus further limiting the potential to 
discover heritable, penetrant genetic risk. This exclusion criterion did not apply in the 
AGP dataset and a small proportion of parents included in the dataset who had been 
screened using these instruments (which is only a small proportion of the sample) meet 
this criteria [45,46]. 
From a phenotypic perspective, when compared to multiplex families, simplex 
family members share less ASD traits [47,48]. Klei et al. [43] have shown that a lower 
proportion (less than 40%) of the heritability of additive effects in ASD is explained in 
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the SSC dataset compared to the AGP (55-59%, 65% for AGP multiplex probands) and 
that family members in the AGP have elevated heritability estimates, which were not 
seen in the SSC. There has been evidence to suggest that genetic transmission 
mechanisms differ between multiplex families and simplex families [7,44,48]. Even 
though both the AGP and SSC datasets are ASD datasets, and even though we would 
expect some shared common risk between the two in terms of associations, we do not 
believe this would be the case for parent-of-origin effects as the transmission 
mechanisms are the main focus. For these reasons, we felt it was not appropriate to treat 
either the AGP or SSC as a replication dataset of the other. Table 1 and Tables S4  S11 
in the SI show that the effects are often in different directions when comparing the AGP 
and SSC results to each other, possibly strengthening the theory that this difference in 
ascertainment leads to a different genetic aetiology for multiplex and simplex ASD 
families. 
Therefore, we have not replicated any of the findings we identified as we did not 
have an appropriate independent replication dataset available. However, we did identify 
some potential parent-of-origin effects in ASD in regions that have been previously 
implicated in ASD. For example, one of the imprinting results (in the STPG2 gene) and 
two of the maternal genetic effects (in the MAML2 gene and the ROBO2 gene) were 
previously implicated in an ASD study for maternal genetic effects by Tsang et al. [18]. 
We also identified a maternal genetic effect at rs5770820 in the SHANK3 gene. 
SHANK3 (ProSAP2) regulates the structural organization of dendritic spines and is a 
binding partner of neuroligins. Mutations in SHANK3 are well known risk factors for 
ASD [49]. Lebold et al. [50] estimated that 0.69% of cases with ASD had heterozygous 
truncating mutations in SHANK3. Sanders et al. [6] has identified SHANK3 as one of the 
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71 risk loci in ASD, although we note that Sanders et al. [6] also used the SSC dataset. 
We identified another maternal genetic effect on chromosome 7q11 in the WBSCR17
gene, which is a deleted region in Williams syndrome. Williams syndrome has strong 
links with ASD as individuals with Williams syndrome often exhibit autistic traits [38]. 
Our findings suggest that mutations in a mothers SHANK3 gene or the WBSCR17 gene 
could increase the likelihood of the offspring having ASD. Although our findings are 
very promising, further investigation is necessary. 
In conclusion, we set out to detect parent-of-origin effects in ASD using the AGP 
and the SSC GWAS datasets. We identified many regions with potential parent-of-
origin effects. This study has also shown an approach to investigating both imprinting 
effects and maternal genetic effects in ASD family GWAS datasets using appropriate 
Bayesian thresholds that take into account the power of the test at each SNP. This 
approach can be used in future studies of ASD when there are larger and more 
appropriate replication datasets available in order to produce robust findings. This 
approach is not limited to ASD but is suitable for the examination of parent-of-origin 
effects in other phenotypes that have GWAS datasets with parental genotypes available. 
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Figure 1: SSC Spectrum Chromosome 22, SHANK3 gene, rs5770820 Mater-
nal Genetic Effect. Regional plot of SNPs highlighted in the SSC Spectrum analysis
for maternal genetic effects (S1, triangles). Markers in linkage disequilibrium with the
index SNP are shown and based on 1000 genomes CEU. Recombination rate plotted in
black. The black dotted line represents the Bayesian threshold for S1.
Table 1: Main Results from the AGP and SSC dataset
AGP Results SSC Results 
SNP Effect P-Value Location 
Previous 
Findings 
Effect P-Value 
rs675680 
IM = 2.36 3.0x10
−6 Chr 4p15 None 
Identified
IM = 0.81 2.4x10
−1
rs10025482 IM = 0.59 6.2x10
−6
Chr 4, C4orf37 gene [18] IM = 1.19 1.5x10
−1
rs4516878 
S
1
= 1.40 1.2x10−5 Chr 5q34 None 
Identified
S
1
= 1.07 3.7x10−1
rs545208 S1 = 0.74 3.0x10
−5 Chr 11, MAML2 gene [18] S1 = 1.02 8.1x10
−1
rs9870610 S1 = 1.33 7.2x10
−5 Chr 3, ROBO2 gene [18] S1 = 1.16 5.0x10
−2
SSC Results AGP Results
SNP Effect P-Value Location
Previous 
Findings
Effect P-Value 
rs9573533 IM = 0.59 8.2x10
−6 Chr 13, TBC1D4 gene None 
Identified
IM = 0.98 8.3x10
−1
rs16890706 IM = 1.86 1.1x10
−5 Chr 6, LRRC16A gene [35] IM = 1.18 2.1x10−1
rs6967953 S1 = 1.38 6.0x10
−6 Chr 7, CHRM2 gene [36] S1 = 0.92 2.0x10
−1
rs5770820 S1 = 1.25 5.5x10
−5 Chr 22, SHANK3 gene [37] S1 = 0.98 8.2x10
−1
rs4719103 S1 = 1.41 5.5x10
−5 Chr 7, WBSCR17 gene [38] S1 = 0.96 6.3x10
−1
rs11075447 S1 = 0.76 9.5x10
−5 Chr 22, GNB1L gene [41] S1 = 1.00 9.5x10
−1
